Category Archives: – Pharma

Pfizer admits it creates man-made viruses, which is super illegal

January 28, 2023- by Steven E. Greer, MD Pfizer commented on a Friday night, with Antifa riots to distract, to address the Project Veritas video that

Posted in - Opinion, - Pharma, - Policy, Cardiology, CDC, Congress, FDA, Infectious disease, Internal Medicine, NIH | Leave a comment

New York Times: Booster shots cause immune system fatigue

December 30, 2021- by Steven E. Greer, MD Einstein’s definition of insanity, to paraphrase, is doing the same thing over and over and expecting different results.

Posted in - Biotech, - NEJM, - Opinion, - Pharma | Leave a comment

How to beat the virus with early treatment

July 22, 2021- by Steven E. Greer, MD I woke up yesterday with a slight malaise and I sneezed once. I knew I had come down with a virus

Posted in - Biotech, - Generics, - Opinion, - Pharma, - Policy, Duke, Emergency medicine, Geriatrics, Infectious disease, Internal Medicine, Pediatrics, Primary care medicine, Pulmonology | Leave a comment

The only thing we have to fear…is fear itself

March 13, 2020- by Steven E. Greer, MD Holy cow. The PGA Tour cancelled the Players Championship due to fears over the coronavirus.

Posted in - Biotech, - Medical Devices, - Opinion, - Pharma, - Policy, CDC, CMS, Congress, Emergency medicine, FDA, Infectious disease, Internal Medicine, NIH, Primary care medicine, Pulmonology, VA | Leave a comment

Florida becomes the first state to recommend against getting the gene therapy “vaccines” for COVID

October 9, 2022- by Steven E. Greer, MD

Posted in - Biotech, - Opinion, - Pharma, - Policy, Cardiology, CDC, FDA, Harvard, Infectious disease, Internal Medicine, Pediatrics, Primary care medicine | Leave a comment

Pfizer documents show vaccine causes high fetal death rates

February 3, 2022- by Steven E. Greer, MD

Posted in - Biotech, - Pharma, FDA, Infectious disease, Internal Medicine, NIH, Obstetrics and Gynecology, Pediatrics | Leave a comment

The new CDC guidelines for prescribing opioid pain pills

June 1, 2016- Interviewed by Steven E. Greer, MD Pain pill prescriptions have quadrupled since the 1990’s as drug companies stepped up marketing and funded

Posted in - JAMA, - NEJM, - Pharma, CDC, Emergency medicine, General surgery, Oncology, Psychology Psychiatry, Rehab, Spine surgery, Sports medicine | Leave a comment

India, Mexico, and El Salvador distribute ivermectin to citizens in free COVID kits

January 20, 2022- by Steven E. Greer, MD As all hospitals in the U.S. refuse to administer lifesaving early treatments for the SARS-CoV-2 coronavirus,

Posted in - Biotech, - Generics, - Medical Devices, - Pharma, - Policy, Infectious disease, Internal Medicine | Leave a comment

Where are those fancy new oral pills from Pfizer and Merck?

January 8, 2022- by Steven E. Greer, MD The Omicron variant is milder but still causing tremendous economic and psychological damage. Schools are closing

Posted in - Opinion, - Pharma, - Policy | Leave a comment

What you need to know about the SARS-CoV-2 coronavirus vaccines

Update March 22, 2021- by Steven E. Greer, MD Tucker Carlson interviewed a surgeon who stated what I have known for many months. The signal

Posted in - Biotech, - Opinion, - Pharma, - Policy, CDC, Congress, FDA, Infectious disease, Internal Medicine, NIH | Leave a comment

Sen. Ron Johnson on the need for early treatment of the Wuhan coronavirus

December 13, 2020- by Steven E. Greer, MD This is straight from my book, Tony’s Virus, chapters 8 and chapter 10.

Posted in - Biotech, - Generics, - Opinion, - Pharma, - Policy, CDC, CMS, Congress, FDA, NIH | Leave a comment

Far-left NeverTrump propaganda has hijacked the peer-review process

June 3, 2020- by Steven E. Greer, MD We are living

Posted in - JAMA, - NEJM, - Opinion, - Pharma, - Policy, Emergency medicine, Infectious disease, Internal Medicine, Pulmonology | 3 Comments

The “surge in new Wuhan virus cases” is great news

June 26, 2020- by Steven E. Greer, MD I called it, once again. On June 9th, I wrote, “This unprecedented communist-party-like anarchy in

Posted in - Biotech, - Opinion, - Pharma, - Policy, Emergency medicine, Infectious disease, Internal Medicine, Pediatrics, Primary care medicine, Pulmonology | 2 Comments

TV Quack Dr. David Agus still likes daily aspirin despite heart guidelines dropping it

March 23, 2019- Updated April 14, 2020 by Steven Greer Nobody has

Posted in - Pharma, Cardiology, CDC, FDA, Oncology | Comments Off on TV Quack Dr. David Agus still likes daily aspirin despite heart guidelines dropping it

Are there any medications to treat coronavirus?

(Also: How infectious and lethal is this Coronavirus COVID-19 compared to regular “flu”?) February 27, 2020- by Steven E. Greer, MD Gilead makes a not-yet-approved antiviral drug called remdisivir and it is being tested right

Posted in - Biotech, - Opinion, - Pharma, - Policy, CDC, Congress, FDA, Geriatrics, Infectious disease, Internal Medicine, NIH, Primary care medicine | 2 Comments

President Trump adopts plan by The Healthcare Channel to bring back drug manufacturing jobs

Update February 26, 2020 By Steven E Greer, MD It is happening for real. Politico reports that the Trump administration is planning on using various

Posted in - Opinion, - Pharma, - Policy, CMS, Congress, FDA | Leave a comment

The ISCHEMIA trial PI, Judith Hochman, makes egregiously unfounded statements on national TV

November 17, 2019- by Steven E. Greer, MD The big news from the 2019 American Heart Association meeting is the large trial known by the acronym ISCHEMIA.

Posted in - Opinion, - Pharma, Cardiac surgery, Cardiology, Congress, FDA, Internal Medicine, NYU, VA | 1 Comment

60 Minutes creates another publicist-paid puff-piece for an unethical medical researcher

December 8, 2019- by Steven E. Greer, MD CBS’ 60 Minutes featured an extremely unethical PhD medical researcher at Harvard named George

Posted in - Biotech, - Opinion, - Pharma, - Policy, CDC, Congress, FDA, Genetics, NIH | Leave a comment

Essay: Opioids coming through the Mexican border are a national security risk

Update January 8, 2019- President Trump quoted from this story tonight during his talk from the Ova

Posted in - Opinion, - Pharma, - Policy, CDC, Congress, FDA, NIH, Primary care medicine, Rehab | Leave a comment

Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma

February 27, 2017- interviewed by Steven E. Greer, MD We interviewed Joaquim Bellmunt, MD, PhD, the Director of the Bladder Cancer Center at Dana-Farber,

Posted in - Biotech, - NEJM, - Pharma, Harvard, Oncology | Leave a comment